Shoreline Biosciences, Inc.

Shoreline Biosciences, Inc.

Biotechnology Research

La Jolla, CA 6,397 followers

Clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells

About us

Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Website
https://www.shorelinebio.com/
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
La Jolla, CA
Type
Privately Held
Founded
2020

Locations

Employees at Shoreline Biosciences, Inc.

Updates

Similar pages

Browse jobs

Funding